Sampling populations of humans across the world: ELSI issues

Annual Review of Genomics and Human Genetics

Volumn 13, Issue , 2012, Pages 395-413

  Knoppers, Bartha Maria ^a   Zawati, Ma'N H ^a   Kirby, Emily S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

biobanks; disease specific studies; longitudinal studies; residual tissue banks

Indexed keywords

CONFIDENTIALITY; GENOTYPE ENVIRONMENT INTERACTION; HEALTH HAZARD; HUMAN; INFORMED CONSENT; LEGAL ASPECT; LONGITUDINAL STUDY; MEDICAL ETHICS; MEDICAL RESEARCH; PRIVACY; REVIEW; SCIENTIST; SEQUENCE ANALYSIS; SOCIAL ASPECT; TECHNOLOGY;

ACCESS TO INFORMATION; DATABASES, NUCLEIC ACID; GENETIC PRIVACY; GENETIC VARIATION; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFORMED CONSENT; INTERNATIONALITY; POPULATION; SEQUENCE ANALYSIS, DNA; TISSUE BANKS;

EID: 84867519442     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-090711-163834     Document Type: Review

References (121)

1. 2ndWorld Conf. Res. Integr. Particip. 2010. Singapore statement on research integrity. 2ndWorld. Conf. Res. Integr., Singapore, July 21-24. http://www.singaporestatement. org
2. Allen J, McNamara B. 2011. Reconsidering the value of consent in biobank research. Bioethics 25:155-66
3. ALSPAC Ethics Law Comm. 2010. Policy guidance regarding divulging biomedical information to individual participants. http://www.bristol. ac. uk/alspac/documents/divulgingbiomed. pdf
4. Ashburn TT, Wilson SK, Eisenstein BI. 2000. Human tissue research in the genomic era of medicine: balancing individual and societal interests. Arch. Intern. Med. 160:3377-84
5. Beskow LM, Burke W. 2010. Offering individual genetic research results: context matters. Sci. Transl. Med. 2:38cm20
6. Bioethics Advis.comm. 2002. Human tissue research. Rep. Bioeth. Advis.comm., Singapore. http://www.bioethics-singapore. org/uploadfile/ 60104%20PMHT%20Research. pdf
7. Budin-Ljosne I, Tasse AM, Knoppers BM, Harris J. 2011. Bridging consent: from toll bridges to lift bridges? BMC Med. Genomics 4:69
8. Burton PR, Fortier I, Knoppers BM. 2009. The global emergence of epidemiological biobanks: opportunities and challenges. In Human Genome Epidemiology: Building the Evidence for Using Genetic Information to Improve Health and Prevent Disease, ed. M Khoury, S Bedrosian, M Gwinn, J Higgins, J Ioannidis, J Little, pp. 77-99. Oxford, UK: Oxford Univ. Press. 2nd ed.
9. Burton PR, Hansell AL, Fortier I, Manolio TA, Khoury MJ, et al. 2009. Size matters: Just how big is big? Int. J. Epidemiol. 38:263-73
10. Cambon-Thomsen A, Ducournau P, Gourraud P-A, Pontille D. 2003. Biobanks for genomics and genomics for biobanks.comp. Funct. Genomics 4:628-34
11. Cambon-Thomsen A, Gudmundur AT, Mabile L. 2011. The role of a bioresource research impact factor as an incentive to share human bioresources. Nat. Genet. 43:503-4
12. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. 2007. Trends in ethical and legal frameworks for the use of human biobanks. Eur. Respir. J. 30:373-82 (Pubitemid 47194191)
13. Can. Inst. Health Res., Nat. Sci. Eng. Res. Counc. Can., Soc. Sci. Humanit. Res. Counc. Can. 2010. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. 2nd ed. http://www.pre. ethics. gc. ca/eng/policy-politique/initiatives/tcps2-eptc2/Default/
14. Can. Inst. Health Res., Nat. Sci. Eng. Res. Counc. Can., Soc. Sci. Humanit. Res. Counc. Can. 2011. The Tri-Agency Framework: Responsible Conduct of Research. http://www.rcr. ethics. gc. ca/eng/policy-politique/framework-cadre/
15. Cassa CA, Savage SK, Taylor PL, Green RC, McGuire AL, Mandl KD. 2012. Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility. Genome Res. 22:421-28
16. Caulfield T. 2009. Minimal risk and large-scale biobank and cohort research. Health Law Rev. 17:1-10
17. Caulfield T, Knoppers BM. 2010. Consent, privacy and research biobanks. Genomics Public Policy Soc. Policy Brief 1, Genome Canada, Ottawa, Ontario
18. Chalmers D. 2011. Viewpoint: Are the research ethics committees working in the best interests of participants in an increasingly globalized research environment? J. Intern. Med. 269:392-95
19. Chokshi DA, Thera MA, Parker M, Diakite M, Makani J, et al. 2007. Valid consent for genomic epidemiology in developing countries. PLoS Med. 4:e95
20. Counc. Eur. 1997. Convention for the protection of human rights and dignity of the human being with regards to the application of biology and medicine: convention on human right and biomedicine. Eur. Treaty Ser. 164, Apr. 4, Oviedo, Spain
21. Counc. Eur. 2006. Recommendation Rec(2006)4 of the Committee of Ministers to member states on research on biological materials of human origin. Adopted by the Committee of Ministers, 958th Meet. Minist. Deputies, Mar. 15
22. Counc. Int. Organ. Med. Sci., World Health Organ. 2002. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva: Counc. Int. Organ. Med. Sci.
23. Counc. Int. Organ. Med. Sci., World Health Organ. 2009. International Ethical Guidelines for Epidemiological Studies. Geneva: Counc. Int. Organ. Med. Sci.
24. de Vries J, Bull S, Doumbo O, Ibrahim M, Mercereau-Puijalon O, et al. 2011. Ethical issues in human genomics research in developing countries. BMC Med. Ethics 12:5
25. Dondorp WJ, de Wert GM. 2010. The "thousand-dollar genome": an ethical exploration. Monit. Rep. Ethics Health, Cent. Ethics Health, The Hague. http://www.gezondheidsraad. nl/sites/default/files/201015E. pdf
26. Edwards SJL, Omar R. 2008. Ethics review of research: in pursuit of proportionality. J. Med. Ethics 34:568-72
27. Elger B. 2008. Anonymization and coding. In Ethical Issues in Governing Biobanks: Global Perspectives, ed. B Elger, N Biller-Andorno, A Mauron, AM Capron, pp. 167-88. Aldershot, UK: Ashgate
28. Eur. Soc. Hum. Genet. PPPC. 2003. Data storage and DNA banking for biomedical research: technical, social and ethical issues. Eur. J. Hum. Genet. 11:906-8
29. FeeroWG, Guttmacher AE, Collins FS. 2010. Genomicmedicine-an updated primer. N. Engl. J. Med. 362:2001-11
30. Fortin S, Pathmasiri S, Grintuch R, Descĥenes M. 2011. "Access arrangements" for biobanks: a fine line between facilitating and hindering collaboration. Public Health Genomics 14:104-14
31. Garrard E, Dawson A. 2005. Whatis the role of the research ethics committee? Paternalism, inducements, and harm in research ethics. J. Med. Ethics 31:419-23 (Pubitemid 40945972)
32. Genet. Alliance BioBank. 2010. Executive summary. Jan. 9. http://www.biobank. org/english/view. asp? x=1364&id=76
33. Genetic Information Nondiscrimination Act of 2008. 2008. Pub. L. No. 110-233, 122 Stat. 881
34. Gertz R. 2008. Withdrawing from participating in a biobank: a comparative study. Eur. J. Health Law 15:381-89
35. Gibbons SMC, Kaye J. 2007. Governing genetic databases: collection, storage and use. KLJ 18:201-8
36. Golding J, Jones R. 2009. Sources of data for a longitudinal birth cohort. Paediatr. Perinat. Epidemiol. 23:51-62
37. Gottweis H, Zatloukal K. 2007. Biobank governance: trends and perspectives. Pathobiology 74:206-11 (Pubitemid 47294501)
38. Greely HT. 2007. The uneasy ethical and legal underpinnings of large-scale genomic biobanks. Annu. Rev. Genomics Hum. Genet. 8:343-64
39. Green ED, Guyer MS. 2011. Charting a course for genomic medicine from base pairs to bedside. Nature 470:204-13
40. Haga SB, Beskow LM. 2008. Ethical, legal, and social implications of biobanks for genetics research. Adv. Genet. 60:505-44
41. Hall MA, King NM, Perdue LH, Hilner JE, Akolkar B, et al. 2010. Biobanking, consent, and commercialization in international genetics research: the type 1 diabetes genetics consortium. Clin. Trials 7:S33-45
42. Hansson MG. 2008. Ethics and biobanks. Br. J. Cancer 100:8-12
43. HanssonMG, Dillner J, Bartram CR, Carlson JA, Helgesson G. 2006. Should donors be allowed to give broad consent to future biobank research? Lancet Oncol. 7:266-69 (Pubitemid 43286456)
44. Hansson SO, Bjorkman B. 2006. Bioethics in Sweden. Camb. Q. Healthc. Ethics 15:285-93 (Pubitemid 43979172)
45. Hawkins A. 2010. Biobanks: Importance, implications and opportunities for genetic counselors. J. Genet. Couns. 19:423-29
46. Helgesson G. 2011. In defense of broad consent. Camb. Q. Healthc. Ethics 21:40-50
47. Hens K, Ĺevesque E, DierickxK. 2011. Children and biobanks: a review of the ethical and legal discussion. Hum. Genet. 130:403-13
48. Hidalgo CA, Blumm N, Barab́asi A-L, Christakis NA. 2009. A dynamic network approach for the study of human phenotypes. PLoS Comput. Biol. 5:e1000353
49. Hoeyer K. 2008. The ethics of research biobanking: a critical review of the literature. Biotechnol. Genet. Eng. Rev. 25:429-52
50. Holm S. 2011. Withdrawing from research: a rethink in the context of research biobanks. Health Care Anal. 19:269-81
51. Human Genes Research Act. 2000. RT I 2000, 104, 685 (Estonia). http://www.legaltext. ee/text/en/X50010. htm
52. Int. Cancer Genome Consort. 2008. Informed consent, access and ethical oversight. In International Cancer Genome Consortium (ICGC) Goals, Structure, Policies and Guidelines, sec. E. 1, pp. 9-14. http://www.icgc. org/files/icgc/ICGC-April-29-2008-en. pdf
53. Int. Cancer Genome Consort. 2010. International network of cancer genome projects. Nature 464:993-98
54. Int. Conf. Harmon. Tech. Requir. Regist. Pharm. Hum. Use. 1996. ICHHarmonised TripartiteGuidelines: Guidelines for Good Clinical Practice E6(R1). Geneva: Int. Conf. Harmon.
55. Int. Hum. Genome Seq. Consort. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921
56. Joly Y, Zeps N, Knoppers BM. 2011. Genomic databases access agreements: legal validity and possible sanctions. Hum. Genet. 130:441-49
57. Kaiser J. 2002. Population databases boom, from Iceland to the US. Science 298:1158-61
58. Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KL. 2009. Public opinion about the importance of privacy in biobank research. Am. J. Hum. Genet. 85:643-54
59. Kaye J. 2011. From single biobanks to international networks: developing e-governance. Hum. Genet. 130:377-82
60. Kiehntopf M, Krawczak M. 2011. Biobanking and international interoperability-samples. Hum. Genet. 130:369-76
61. Knoppers BM, Abdul-Rahman MH. 2008. Biobanks in the literature. In Ethical Issues in Governing Biobanks:Global Perspectives, ed. BElger, NBiller-Andorno, AMauron, AMCapron, pp. 13-22. Aldershot, UK: Ashgate
62. Knoppers BM, Abdul-Rahman MH. 2009. Health privacy in genetic research. Politics Life Sci. 28:99-101
63. Knoppers BM, Avard D, Cardinal G, Glass KC. 2002. Children and incompetent adults in genetic research: consent and safeguards. Nat. Rev. Genet. 3:221-25 (Pubitemid 34506590)
64. Knoppers BM, Harris J, Tasse A, Budin-Ljosne I, Kaye J, et al. 2011. Towards a data sharing code of conduct for international genomic research. Genome Med. 3:46
65. Knoppers BM, Kharaboyan L. 2009. "Deconstructing" biobank communication of results. SCRIPTed 6:677-84
66. Knoppers BM, Laberge C. 1989. DNA sampling and informed consent. Can. Med. Assoc. J. 140:1023-28 (Pubitemid 19131514)
67. Knoppers BM, Laberge C. 1995. Research and stored tissues. JAMA 274:1806-7
68. Knoppers BM, Laberge C. 2009. Return of "accurate" and "actionable" results: yes! Am. J. Bioeth. 9:107-9
69. Knoppers BM, Leroux T, Doucet H, Godard B, Laberge C, et al. 2010. Framing genomics, public health research and policy: points to consider. Public Health Genomics 13:224-34
70. Knoppers BM, Saginur M. 2005. The Babel of genetic data terminology. Nat. Biotechnol. 23:539-45
71. Knoppers BM, Zawati MH. 2011. Population biobanks and access. In Il Governo del Corpo: Trattato di Biodiritto, ed. S Rodota, P Zatti, pp. 1181-94. Milan: Giuffr̀e Editore
72. Laurie G, Mallia P, Frenkel DA, Krajewska A, Moniz H, et al. 2010. Managing access to biobanks: How can we reconcile individual privacy and public interests in genetic research? Med. Law Int. 10:315-37
73. Levitt M. 2011. Relating to participants: How close do biobanks and donors really want to be? Health Care Anal. 19:220-30
74. LifeGene Ethics Group. 2010. LifeGene Ethics Policy, Version 4. 3. Stockholm: LifeGene. http://www.lifegene. se/PageFiles/104/20100916-LifeGene- Ethics-Policy4. 3. docx
75. Lochmuller H, Ayḿee S, Pampinella F, Melegh B, Kuhn KA, et al. 2009. The role of biobanking in rare diseases: European consensus expert group report. Biopreserv. Biobank. 7:155-56
76. Malin B, Loukides G, Benitez K, Clayton E. 2011. Identifiability in biobanks: models, measures, and mitigation strategies. Hum. Genet. 130:383-92
77. Mardis ER. 2010. The $1, 000 genome, the $100, 000 analysis? Genome Med. 2:84
78. Mardis ER. 2011. A decade's perspective on DNA sequencing technology. Nature 470:198-203
79. Marshfield Clin. Res. Found. 2010. Research consent/authorization form. http://www.marshfieldclinic. org/chg/pages/Proxy. aspx?Content=MCRF-Centers-CHG- Core-Units-PMRP-consent-form-3-24-10. 1. pdf
80. Master Z, Ries N, Caulfield T. 2011. Balancing efficiency and the protection of research participants: Canadian allergy/asthma researchers' perspectives on the ethics review of multi-site health research. J. Clin. Res. Bioeth. 2:104e
81. McCarty C, Chisholm R, Chute C, Kullo I, Jarvik G, et al. 2011. The emerge network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med. Genomics 4:13
82. Meslin EM, Quaid KA. 2004. Ethical issues in the collection, storage, and research use of human biological materials. J. Lab. Clin. Med. 144:229-34 (Pubitemid 39573228)
83. Mitchell R, Waldby C. 2010. National biobanks: clinical labor, risk production, and the creation of biovalue. Sci. Technol. Hum. Values 35:330-55
84. Need AC, Goldstein DB. 2009. Next generation disparities in human genomics: concerns and remedies. Trends Genet. 25:489-94
85. Nuremberg Code. 1947. In Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law No. 10, 2:181-82. Washington, DC: US Gov. Print. Off.
86. Off. Biorepos. Biospec. Res., Natl. Cancer Inst., Natl. Inst. Health. 2011. Workshop on release of research results to participants in biospecimen studies. Workshop Summ., Bethesda, MD, July 8-9, 2010. http://biospecimens. cancer. gov/global/pdfs/NCI-Return-Research-Results-Summary-Final-508. pdf
87. Off. Popul. Health Genomics. 2010. Guidelines for Human Biobanks, Genetic Research Databases and Associated Data. Perth, Australia: Gov. West. Aust. Dep. Health
88. Ont. Health Stud. 2009. Participant consent form. http:// ontariohealthstudy. ca/files/B4%20Consent% 20Form%20ENG. pdf
89. Oosterhuis JW, Coebergh JW, van Veen E-B. 2003. Tumour banks: well-guarded treasures in the interest of patients. Nat. Rev. Cancer 3:73-77 (Pubitemid 37328889)
90. Organ. Econ. Coop. Dev. 2008. Draft Guidelines for Human Biobanks and Genetic Research Databases. Paris: Organ. Econ. Coop. Dev.
91. Petrini C. 2010. "Broad" consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose. Soc. Sci. Med. 70:217-20
92. PHG Found. 2011. Next Steps in the Sequence: The Implications of Whole Genome Sequencing for Health in the UK. Cambridge: PHG Found. http://www.phgfoundation. org/pages/wholegenome. htm
93. Ponder M, Statham H, Hallowell N, Moon JA, Richards M, Raymond FL. 2008. Genetic research on rare familial disorders: consent and the blurred boundaries between clinical service and research. J. Med. Ethics 34:690-94
94. Public Popul. Proj. Genomics. 2011. Population studies: return of research results and incidental findings. Policy statement, Public Popul. Proj. Genomics, Montreal. http://www.p3g. org/secretariat/news/ P3G%20Return%20of%20Results. pdf
95. Pulley J, Clayton E, Bernard GR, RodenDM, MasysDR. 2010. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin. Transl. Sci. 3:42-48
96. Riegman PH, Bosch AL, OECI TuBaFrost Consort. 2008. OECI TuBaFrost tumor biobanking. Tumori 94:160-63 (Pubitemid 351838820)
97. Riegman PH, van Veen E-B. 2011. Biobanking residual tissues. Hum. Genet. 130:357-68
98. Roses AD. 2000. Pharmacogenetics and the practice of medicine. Nature 405:857-65 (Pubitemid 30407864)
99. Rothstein MA. 2005. Expanding the ethical analysis of biobanks. J. Law Med. Ethics 33:89-101 (Pubitemid 40598047)
100. Sharp RR. 2011. Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small. Genet. Med. 13:191-94
101. Sheehan M. 2011. Can broad consent be informed consent? Public Health Ethics 4:226-35
102. Simon CM, L'Heureux J, Murray JC, Winokur P, Weiner G, et al. 2011. Active choice but not too active: public perspectives on biobank consent models. Genet. Med. 13:821-31
103. Skloot R. 2010. The Immortal Life of Henrietta Lacks. New York: Crown. 384 pp.
104. Swede H, Stone CL, Norwood AR. 2007. National population-based biobanks for genetic research. Genet. Med. 9:141-49 (Pubitemid 46597711)
105. Tamir S. 2010. Direct-to-consumer genetics testing: ethical-legal perspectives and practical considerations. Med. Law Rev. 18:213-38
106. Tasśe AM. 2011. Biobanking and deceased persons. Hum. Genet. 130:415-23
107. Tucker T, Marra M, Friedman JM. 2009. Massively parallel sequencing: the next big thing in genetic medicine. Am. J. Hum. Genet. 85:142-54
108. UK Biobank. 2007. UK Biobank ethics and governance framework. http://www.ukbiobank. ac. uk/wp-content/uploads/2011/05/EGF20082. pdf
109. UK Biobank. 2011. Access procedures: application and review procedures for access to the UK Biobank resource. http://www.ukbiobank. ac. uk/wp-content/uploads/2011/11/Access-Procedures-Nov-2011. pdf
110. UN Educ. Sci. Cult. Organ. 2002. Human genetic data: preliminary study by the IBC on its collection, processing, storage and use. Rep. SHS-503/01/CIB-8/3, UN Educ. Sci. Cult. Organ., Paris
111. UN Educ. Sci. Cult. Organ. 2003. International declaration on human genetic data. Rec. Gen. Conf., 32nd, Paris, Sept. 29-Oct. 17, pp. 39-46. Paris: UN Educ. Sci. Cult. Organ.
112. van Veen EB, Riegman PHJ, Dinjens WNM, Lam KH, Oomen MHA, et al. 2006. TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur. J. Cancer 42:2914-23 (Pubitemid 44767664)
113. Vermeulen E, Schmidt MK, Aaronson NK, Kuenen M, van der Valk P, et al. 2009. Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment. J. Clin. Pathol. 62:275-78
114. Wallace S, Kent A. 2011. Population biobanks and returning individual research results: mission impossible or new directions? Hum. Genet. 130:393-401
115. Warner AW, Bhathena A, Gilardi S, Mohr D, Leong D, et al. 2011. Challenges in obtaining adequate genetic sample sets in clinical trials: the perspective of the industry pharmacogenomics working group. Clin. Pharmacol. Ther. 89:529-36
116. Watson RWG, Kay EW, SmithD. 2010. Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research. Nat. Rev. Cancer 10:646-51
117. Wilson S, Draper H, Ives J. 2008. Ethical issues regarding recruitment to research studies within the primary care consultation. Fam. Pract. 25:456-61
118. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, et al. 2008. Managing incidental findings in human subjects research: analysis and recommendations. J. Law Med. Ethics 36:219-48
119. World Med. Assoc. 2008. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Adopted by the 18thWMA General Assembly, Helsinki, Finland, June 1964, amended in 1975, 1983, 1989, 1996, 2000, 2002, 2004, and 2008
120. Zawati MH, Rioux A. 2011. Biobanks and the return of research results: out with the old and in with the new? J. Law Med. Ethics 39:614-20
121. Zika E, Paci D, Braun A, Rijkers-Defrasne S, Descĥenes M, et al. 2011. A European survey on biobanks: trends and issues. Public Health Genomics 14:96-103